Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Angiotensin receptor blockers modulate the lupus CD4+ T cell epigenome characterized by TNF family–linked signaling
Andrew P. Hart, Jonathan J. Kotzin, Steffan W. Schulz, Jonathan S. Dunham, Alison L. Keenan, Joshua F. Baker, Andrew D. Wells, Daniel P. Beiting, Terri M. Laufer
Andrew P. Hart, Jonathan J. Kotzin, Steffan W. Schulz, Jonathan S. Dunham, Alison L. Keenan, Joshua F. Baker, Andrew D. Wells, Daniel P. Beiting, Terri M. Laufer
View: Text | PDF
Research Article Immunology

Angiotensin receptor blockers modulate the lupus CD4+ T cell epigenome characterized by TNF family–linked signaling

  • Text
  • PDF
Abstract

In systemic lupus erythematosus (lupus), environmental effects acting within a permissive genetic background lead to autoimmune dysregulation. Dysfunction of CD4+ T cells contributes to pathology by providing help to autoreactive B and T cells, and CD4+ T cell dysfunction coincides with altered DNA methylation and histone modifications of select gene loci. However, chromatin accessibility states of distinct T cell subsets and mechanisms driving heterogeneous chromatin states across patients remain poorly understood. We defined the transcriptome and epigenome of multiple CD4+ T cell populations from patients with lupus and healthy individuals. Most patients with lupus, regardless of disease activity, had enhanced chromatin accessibility bearing hallmarks of inflammatory cytokine signals. Single-cell approaches revealed that chromatin changes extended to naive CD4+ T cells, uniformly affecting naive subpopulations. Transcriptional data and cellular and protein analyses suggested that the TNF family members, TNF-α, LIGHT, and TWEAK, were linked to observed molecular changes and the altered lupus chromatin state. However, we identified a patient subgroup prescribed angiotensin receptor blockers (ARBs), which lacked TNF-linked lupus chromatin accessibility features. These data raise questions about the role of lupus-associated chromatin changes in naive CD4+ T cell activation and differentiation and implicate ARBs in the regulation of disease-driven epigenetic states.

Authors

Andrew P. Hart, Jonathan J. Kotzin, Steffan W. Schulz, Jonathan S. Dunham, Alison L. Keenan, Joshua F. Baker, Andrew D. Wells, Daniel P. Beiting, Terri M. Laufer

×

Figure 1

Lupus Th cells retain open chromatin features that define T cell subsets.

Options: View larger image (or click on image) Download as PowerPoint
Lupus Th cells retain open chromatin features that define T cell subsets...
(A) Representative gating strategy to purify CD45RA+CD27+ naive Th, CXCR5+PD1+ICOS+CD38+ AcTfh, CXCR5+PD1+ICOS–CD38– cTfh, and CXCR5–PD1–CXCR3+ Th1 cells. PD1, programmed cell death 1; AcTfh, effector Tfh; cTfh, circulating Tfh. (B) Frequency of non-naive Th cells among CD4+ T cells in lupus (n = 14) and healthy individuals (n = 15) by flow cytometry. (C) Frequency of CXCR5+PD1+ T cells among CD4+ T cells in lupus (n = 14) and healthy individuals (n = 15). (D) Frequency of AcTfh cells among CD4+ T cells in lupus (n = 14) and healthy individuals (n = 15). (E) Principal component analysis (PCA) (PC1 × PC2) of ATAC-Seq data for sorted Th cell populations. (F) PCA (PC1 × PC5) of ATAC-Seq data for sorted Th cell populations. Colors distinguish lupus or healthy samples and shapes distinguish Th cell subsets. (G) The 10 most significant ChipEnrich pathway enrichment results for peaks defining non-naive CD4+ T cells in PC1. (H) Sample-wise peak-set variation analysis of ATAC-Seq data across lupus and healthy Th cell populations against published chromatin peaks enriched in naive Th cells. (I) Sample-wise peak-set variation analysis of published chromatin peaks enriched in GC Tfh cells across lupus and healthy Th cell populations. Error is reported as SD. ATAC-Seq data represent 25 naive Th cell samples (13 lupus, 12 healthy), 8 Th1 samples (4 lupus, 4 healthy), 24 cTfh samples (12 lupus, 12 healthy), and 24 AcTfh samples (12 lupus, 12 healthy). *P < 0.05, unpaired 2-tailed t tests (B–D, H, and I).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts